Prudent Man Investment Management, Inc.
Position in GILD — Gilead Sciences, Inc.
CIK 2054263
LOUISVILLE, CO
Position in GILD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$16,676
-$1,720 QoQ
Shares Held
132
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#2,149
of 2,266 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prudent Man Investment Management, Inc. holds $279,538 across 8 Drug Manufacturers - General names. GILD ranks #4 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
350 | $88,889 | |
| 2 | LLY |
ELI LILLY & Co
|
71 | $85,159 | |
| 3 | ABBV |
AbbVie Inc.
|
215 | $54,102 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
132 | $16,676 | |
| 5 | NVS |
Novartis AG
|
84 | $13,164 | |
| 6 | MRK |
Merck & Co., Inc.
|
100 | $12,850 | |
| 7 | GSK |
GSK plc
|
120 | $6,290 | |
| 8 | PFE |
Pfizer Inc
|
100 | $2,408 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,676 | 132 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $18,396 | 132 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $16,201 | 132 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $14,652 | 132 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $14,634 | 132 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $14,790 | 132 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $12,192 | 132 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||